chr14-21570435-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005465.2(OR10G3):āc.310T>Cā(p.Phe104Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,613,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005465.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR10G3 | NM_001005465.2 | c.310T>C | p.Phe104Leu | missense_variant | 2/2 | ENST00000641040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR10G3 | ENST00000641040.1 | c.310T>C | p.Phe104Leu | missense_variant | 2/2 | NM_001005465.2 | P1 | ||
OR10G3 | ENST00000641185.1 | c.310T>C | p.Phe104Leu | missense_variant | 3/3 | P1 | |||
OR10G3 | ENST00000641655.1 | n.292-354T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251374Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135856
GnomAD4 exome AF: 0.000166 AC: 242AN: 1461150Hom.: 0 Cov.: 65 AF XY: 0.000176 AC XY: 128AN XY: 726850
GnomAD4 genome AF: 0.000236 AC: 36AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.310T>C (p.F104L) alteration is located in exon 1 (coding exon 1) of the OR10G3 gene. This alteration results from a T to C substitution at nucleotide position 310, causing the phenylalanine (F) at amino acid position 104 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at